Related by context. All words. (Click for frequent words.) 68 IRX 2 67 picoplatin 65 OncoVEX GM CSF 65 Panzem R 65 targeted radiotherapeutic 65 Arimoclomol 64 Fodosine 64 Archexin 64 oxybutynin ATD TM 64 Onconase 64 liposomal formulation 64 Pralatrexate 63 Panzem R NCD 63 investigational drug 63 PORxin TM 63 Perifosine 63 TBC# 63 targeted antifolate 63 investigational pharmacologically unique 63 proteasome inhibitor 63 SinuNase TM 63 candidate deforolimus 62 Celacade TM technology 62 Satraplatin 62 metaglidasen 62 anticancer compound 62 IMA# 62 Civacir 62 investigational humanized monoclonal antibody 62 Pirfenidone 62 Personalized Immunotherapy 62 Bezielle 62 Dapagliflozin 62 radiation sensitizer 61 MGCD# [001] 61 Troxatyl 61 PI3K/Akt pathway inhibitor 61 INCB# [001] 61 Amrubicin 61 Cannabinor 61 PLK1 SNALP 61 mertansine 61 investigational monoclonal antibody 61 OvaRex ® MAb 61 TYZEKA 61 Fx #A 61 histamine dihydrochloride 61 Nexavar ® 61 CEQ# 61 Soliris eculizumab 61 Proxinium TM 61 IgG1 monoclonal antibody 61 Allovectin 7 61 Daclizumab 61 forodesine hydrochloride 61 virus HCV protease inhibitor 61 Genasense ® oblimersen 61 HQK 61 torezolid phosphate 61 MAP# 61 Omacetaxine 61 PDX pralatrexate 61 VitiGam 61 Fibrin Pad 61 HEPLISAV TM 61 Maribavir 61 oral prodrug 60 Clofarabine 60 HCV protease inhibitors 60 Marqibo 60 pralatrexate 60 Elesclomol 60 RDEA# 60 CB2 selective receptor agonist 60 PrevOnco ™ 60 Chrysalin 60 MAXY G# 60 investigational immunotherapy 60 KRN# 60 sorafenib tablets 60 LEVADEX TM 60 seliciclib CYC# 60 APF# 60 tiapamil 60 mitogen activated ERK kinase 60 LEP ETU 60 depsipeptide 60 Factor VIIa 60 Dalbavancin 60 Aflibercept 60 YONDELIS 60 RhuDex ® 60 humanized monoclonal antibody 60 Aviptadil 60 refractory gout 60 Aurexis 60 BCR ABL inhibitors 60 DermaVir Patch 60 SPRYCEL ® 60 PDE4 inhibitor 60 LHRH antagonist 60 PrevOnco 60 Hsp# Inhibitor 59 oral Factor Xa 59 UPLYSO 59 hormone LHRH antagonist 59 nanoviricide drug 59 Golimumab 59 Neo Urinary Conduit 59 Sym# 59 reslizumab 59 vemurafenib 59 EFAPROXYN 59 dermal patch 59 candidate REP# 59 Tarvacin TM 59 Everolimus 59 Vandetanib 59 Iluvien ® 59 Chemophase 59 CCR5 antagonist 59 elacytarabine 59 Alpharadin 59 phase IIa clinical 59 Traficet EN 59 Besivance 59 BAY #-# 59 faropenem medoxomil 59 histone deacetylase HDAC inhibitor 59 Vicriviroc 59 histone deacetylase inhibitor 59 mild vasodilator 59 orally bioavailable 59 investigational antiplatelet agent 59 metastatic carcinoid 59 Amigal 59 Gemzar ® 59 Azedra 59 AEG# 59 Hyphanox 59 JAK inhibitor 59 vascular disrupting agent 59 PEG SN# 59 Boceprevir 59 FOLOTYN ® 59 cangrelor 59 Ceflatonin 59 acyclovir Lauriad R 59 MAGE A3 ASCI 59 phase IIb clinical 59 Vilazodone 59 L BLP# 59 Zybrestat 59 pertuzumab 59 Mipomersen 59 Muraglitazar 59 Cintredekin Besudotox 59 Ofatumumab 59 OvaRex R 59 Cleviprex TM clevidipine 59 DOS# 59 Amplimexon 59 MEK inhibitors 59 systemic immunosuppressive drugs 59 novel VDA molecule 59 Noxafil 59 Pradefovir 58 Tezampanel 58 Eculizumab 58 Onrigin 58 Radezolid 58 Reolysin 58 dasatinib Sprycel 58 topically applied SEPA 58 taxane 58 Anidulafungin 58 orally administered inhibitor 58 immunotherapeutic 58 Rilonacept 58 Pazopanib 58 PNP inhibitor 58 investigational pan BCR 58 BrachySil 58 Ambrisentan 58 treat chronic sinusitis 58 Cloretazine 58 MKC# MT 58 OncoVEX 58 Pemetrexed 58 mapatumumab 58 alvimopan 58 Talabostat 58 NeuroSTAT ® 58 sorafenib Nexavar 58 candidate AP# 58 ALN TTR# 58 CCX# 58 HuMax EGFr 58 Elagolix 58 Onalta ™ 58 novel peptide 58 Luteinizing Hormone Releasing Hormone 58 LibiGel ® 58 ATL# [001] 58 Tesetaxel 58 humanized anti 58 lucinactant 58 Androxal TM 58 Phase 2a clinical 58 ProLindac TM 58 preclinical efficacy 58 Silodosin 58 Trimesta 58 Vernakalant 58 dasatinib Sprycel ® 58 Vicinium TM 58 NP2 Enkephalin 58 Anticalin R 58 Ustekinumab 58 mTOR inhibitor 58 orally administered 58 immunotherapeutic agent 58 TAFA# 58 somatostatin analogue 58 NEUMUNE 58 TELCYTA 58 Ozarelix 58 Carfilzomib 58 Phase 1b clinical 58 oral antiviral 58 vorinostat 58 forodesine 58 MyVax ® 58 Allovectin 7 R 58 #D#C# 58 ILUVIEN ® 58 pomalidomide 58 antisense drug 58 Tolvaptan 57 BENLYSTA ® 57 PD LID 57 antibody MAb 57 DORIBAX 57 Ixempra 57 Safinamide 57 huC# DM4 57 Ecallantide 57 MEK inhibitor 57 Iluvien TM 57 Serdaxin 57 Factor Xa inhibitor 57 Dyloject TM 57 Zelrix 57 LEVADEX ™ 57 ketolide antibiotic 57 vinca alkaloid 57 Phase #b/#a clinical 57 Corlux 57 Fibrillex TM 57 ZYBRESTAT 57 immunotherapeutic vaccine 57 relapsed multiple myeloma 57 Tyrima 57 Vascugel 57 immunomodulator 57 Afatinib 57 peripherally acting 57 Irinotecan 57 Ticagrelor 57 pegylated interferons 57 TREANDA 57 Tamibarotene 57 biologic therapy 57 rNAPc2 57 Gleevec resistant 57 transcriptase inhibitor NNRTI 57 OMNARIS HFA 57 thalidomide Thalomid 57 alvespimycin 57 immune modulatory 57 tolevamer 57 EcoNail 57 amrubicin 57 autologous cellular immunotherapy 57 EOquin TM 57 PROVENGE sipuleucel T 57 relapsed leukemia 57 Cethromycin 57 rilonacept 57 IL# PE#QQR 57 pharmacokinetic PK study 57 novel oral anticoagulant 57 Phase IIa clinical 57 MyVax R 57 CA4P 57 ixabepilone 57 rasagiline tablets 57 IMiDs R 57 MOZOBIL 57 refractory Hodgkin lymphoma 57 ELACYT 57 miconazole Lauriad R 57 Telavancin 57 alkylating agent 57 lintuzumab SGN 57 ADVEXIN 57 Hepatitis C virus HCV 57 Cloretazine ® 56 lapatinib Tykerb 56 XL# anticancer compounds 56 Elvitegravir 56 PKC# 56 Insegia 56 Familial Adenomatous Polyposis FAP 56 superficial bladder cancer 56 TG# [003] 56 Laquinimod 56 Nanobody 56 mRCC 56 oral ridaforolimus 56 Microplasmin 56 multi kinase inhibitor 56 thymalfasin 56 EOquin 56 satraplatin 56 TELINTRA 56 Diamyd ® 56 RSD# 56 PEGylated Fab fragment 56 nucleoside analogue 56 anticancer agent 56 Qutenza TM 56 Alemtuzumab 56 synthetic retinoid 56 REG1 56 NV1FGF 56 perifosine 56 TLK# 56 Telaprevir 56 bevirimat 56 HCV protease inhibitor 56 lorvotuzumab mertansine 56 SCH # 56 ganetespib 56 Mycamine 56 StemEx R 56 EndoTAG TM 56 cilengitide 56 castrate resistant prostate cancer 56 Trofex 56 cathepsin K inhibitor 56 CCR5 inhibitor 56 ALK inhibitor 56 docetaxel Taxotere ® 56 Pimavanserin 56 tanespimycin 56 SNT-MC#/idebenone 56 temsirolimus 56 RANK Ligand inhibitor 56 6R BH4 56 BiTE antibody 56 BN# [002] 56 Cloretazine R VNP#M 56 allogeneic cell 56 Cytolin ® 56 investigational therapies 56 BARACLUDE R 56 Veronate 56 Zingo TM 56 Aerosurf 56 Nebido 56 bortezomib Velcade 56 Cimzia TM 56 OHR/AVR# 56 Arcalyst 56 angiogenesis inhibitor 56 eltrombopag 56 selective immunoproteasome inhibitor 56 Etravirine 56 non nucleoside HCV 56 LE SN# 56 investigational hepatitis C 56 QRxPharma 56 Rasagiline 56 Aplidin 56 OXi# 56 SERMs 56 selective modulator 56 efficacy tolerability 56 CTLA4 Ig 56 OncoGel 56 Mitoxantrone 56 Toctino ® alitretinoin 56 Interferon alpha 56 Icatibant 56 Zoraxel 56 Romiplostim 56 cannabinor 56 Soliris TM eculizumab 55 either acutely decompensated 55 Lacosamide 55 ATPace TM 55 erlotinib Tarceva ® 55 Apixaban 55 Vidaza azacitidine 55 DP b# 55 docetaxel Taxotere 55 GRNVAC1 55 vidofludimus 55 Hycamtin 55 uric acid lowering 55 idiopathic pulmonary fibrosis IPF 55 BYETTA ® 55 Plenaxis TM 55 Cetrorelix 55 nucleotide analog 55 Ramelteon 55 Aliskiren 55 MBP# [001] 55 aflibercept 55 liprotamase 55 Alferon N 55 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 55 CDP# 55 ABL inhibitor 55 visilizumab 55 novel histone deacetylase 55 selective kinase inhibitor 55 IAP inhibitors 55 oral anticoagulant 55 PS# [001] 55 Pivotal Phase III 55 Reverset 55 lomitapide 55 Therapeutic Vaccine 55 ospemifene 55 HuMax CD4 55 Acute Radiation Syndrome ARS 55 PEGylated anti 55 ASONEP 55 intravenous acetaminophen 55 bevacizumab Avastin 55 Gleevec imatinib mesylate 55 Tarceva TM 55 Neuvenge 55 Inhalation Solution 55 investigational 55 lenalidomide Revlimid R 55 Alvesco R 55 non nucleoside reverse 55 Indaflex TM 55 romidepsin 55 LymphoStat B TM 55 Teriparatide 55 Methylnaltrexone 55 Q#IR 55 trastuzumab DM1 T DM1 55 romiplostim 55 castration resistant prostate cancer 55 anticancer therapies 55 antiplatelet agent 55 Phase Ib IIa 55 telbivudine 55 DU #b 55 drug eluting stent DES 55 Dabigatran etexilate 55 AEGR 55 Pafuramidine 55 Anturol TM 55 Maraviroc 55 Cancidas 55 etanercept Enbrel 55 ICA # 55 pemetrexed Alimta 55 TEMODAL 55 NGX# 55 small molecule chemotherapeutic 55 Copegus ribavirin 55 AP# [003] 55 Romidepsin 55 Phase Ib clinical 55 Clevudine 55 intranasal formulation 55 NOXAFIL 55 Triolex 55 investigational hepatitis B 55 rALLy clinical trial 55 LPM TM 55 bardoxolone methyl 55 pegfilgrastim 55 Phase Ib clinical trials 55 EZN 55 cysteamine bitartrate 55 BEMA TM Fentanyl 55 oral rivaroxaban 55 Teriflunomide 55 Aryplase 55 R roscovitine 55 Excellagen 55 carfilzomib 55 Darusentan 55 CCR5 mAb 54 Torisel 54 Sprycel dasatinib 54 oral anticancer 54 multicenter Phase II 54 Altropane 54 StemEx 54 Azathioprine 54 BiTE 54 Phase III Clinical Trial 54 Bucindolol 54 BRIM2 54 DB# [003] 54 Combivir Kivexa 54 ReN# 54 Ciclesonide 54 tezampanel 54 Nexavar sorafenib 54 subcutaneous formulation 54 nosocomial pneumonia 54 Tasigna nilotinib 54 investigational integrase inhibitor 54 generation purine nucleoside 54 nucleoside analog 54 EP #R 54 adipiplon 54 Onco TCS 54 Nipent R 54 Avanafil 54 AZILECT R 54 Herceptin trastuzumab 54 Urocidin 54 Imprime PGG 54 Anthim 54 Alinia 54 Allovectin 7 ® 54 JAK2 inhibitor 54 panitumumab Vectibix 54 targeting CD# 54 PEG Interferon lambda 54 Junovan 54 telaprevir VX 54 metastatic hormone refractory 54 Liprotamase 54 ZOLINZA 54 MKC# MKC# PP 54 elvucitabine 54 GLPG# 54 antifibrotic 54 Zenvia ™ 54 investigational protease inhibitor 54 Exalgo TM 54 Phase IIb clinical trials 54 BrachySil TM 54 LEUKINE 54 selective A2A adenosine receptor 54 Emend 54 Diabetic Macular Edema 54 stage chemoresistant ovarian 54 Cloretazine R 54 Dacogen injection 54 trastuzumab Herceptin 54 Canvaxin 54 lexidronam injection 54 tigecycline 54 Pfizer Sutent 54 diabetic neuropathic pain 54 AAG geldanamycin analog 54 candidate AQ4N 54 Rivaroxaban 54 receptor tyrosine kinase inhibitor 54 Genasense ® 54 boosted protease inhibitor 54 Lixivaptan 54 Racivir 54 ORENCIA ® 54 HepaSphere 54 atacicept 54 Tanespimycin 54 SNT MC# 54 refractory ovarian cancer 54 INTELENCE 54 metastatic renal cell carcinoma 54 relapsed ovarian cancer 54 CANCIDAS 54 MyVax 54 RGB # 54 IMiD 54 transcriptase inhibitor 54 acyclovir Lauriad ® 54 ELND# 54 CIPN 54 methylnaltrexone bromide 54 cidofovir 54 IV Busulfex 54 daptomycin 54 nucleoside analogues 54 drug eluting coronary stent 54 Zolinza 54 T Pred 54 refractory multiple myeloma 54 inhaled formulation 54 adalimumab Humira 54 Phase Ib study 54 Tarceva erlotinib 54 teriflunomide 54 axitinib 54 phase Ib 54 TRANSDUR Sufentanil 54 IMP# 54 oral methylnaltrexone 54 FASLODEX 54 CINTREDEKIN BESUDOTOX 54 cintredekin besudotox 54 Arranon 54 Cetrorelix pamoate 54 icatibant 54 Advexin 54 Fabry Disease 54 LymphoStat B 54 acadesine 54 MabCampath 54 INT# [002] 54 BCR ABL inhibitor 53 tyrosine kinase inhibitor TKI 53 gallium nitrate injection 53 tyrosine kinase inhibitor 53 MNTX 53 volociximab 53 malignant ascites 53 peptibody 53 Prednisporin TM 53 buccal insulin spray 53 investigational compounds 53 Clolar 53 Bone Graft 53 organ transplant rejection 53 pharmacokinetic PK 53 pancreatic enzyme replacement 53 chronic myeloid leukemia CML 53 Pegylated Interferon 53 NKTR 53 Phase IIb trials 53 cediranib 53 diarrhea predominant irritable 53 Bioral ® 53 ZFP Therapeutic 53 Crizotinib 53 VIR# 53 LE DT 53 integrase inhibitor 53 sunitinib malate 53 Cerashield 53 orally dosed 53 octreotide acetate 53 NXL# 53 Glycopyrrolate 53 Rituxan rituximab 53 PSN# [002] 53 Milnacipran 53 Viramidine 53 Sebivo 53 radiotherapeutic 53 CYT# 53 ONGLYZA ™ 53 Yondelis ® 53 HCD# [002] 53 Eltrombopag 53 phase III isavuconazole 53 investigational oral 53 Cellegesic 53 Topotecan 53 Tocilizumab 53 EGFR inhibitors 53 Tygacil 53 hypoxia activated prodrug 53 prGCD 53 SomatoKine 53 Rescula 53 riociguat 53 SIR Spheres 53 anti arrhythmic 53 Humira adalimumab 53 ALVESCO R 53 Phase Ib II 53 Phase Ib 53 serotonin norepinephrine reuptake inhibitor 53 Proellex TM 53 dalbavancin 53 Tofacitinib 53 HZT 53 DPP4 inhibitor 53 hormone refractory prostate cancer 53 Prodarsan ® 53 Squalamine 53 CRx 53 cancer immunotherapy 53 Velcade bortezomib 53 BCX# 53 hyaluronidase enzyme 53 IAP inhibitor 53 Frova ® 53 neratinib 53 FACTIVE R gemifloxacin 53 tafamidis 53 Levoleucovorin 53 Pancreas Cancer Vaccine 53 Gleevec imatinib 53 ongoing Phase 1b 53 Amphotericin B 53 investigational compound 53 herpetic keratitis 53 Nimotuzumab 53 TM Drug Eluting 53 VEGF inhibitor 53 noninfectious uveitis 53 Sustiva efavirenz 53 Junovan TM 53 novel immunomodulatory 53 relapsing multiple sclerosis 53 phenylketonuria PKU 53 Folotyn 53 polymerase inhibitor 53 small molecule tyrosine 53 registrational 53 Blinatumomab 53 Raptiva ® 53 SEPET TM 53 recurrent ovarian cancer 53 Clonicel 53 hepatitis C HCV 53 GAMMAGARD 53 Liposomal 53 #I TM# 53 Kepivance 53 injectable formulations 53 protease inhibitor PI 53 RNAi therapeutic targeting 53 Avastin bevacizumab 53 non alcoholic steatohepatitis 52 ADAGIO study 52 Phenoptin 52 maximally tolerated dose 52 Bronchitol 52 topical NSAID 52 nitazoxanide 52 Thiovir 52 SUTENT ® 52 alogliptin 52 Zenpep 52 GLP toxicology studies 52 Dificid 52 Recombinant interferon alpha 52 NexACT 52 Phase III clinical trials 52 omacetaxine 52 methylnaltrexone 52 AQ4N 52 Phase #b/#a trial 52 Xyrem ® 52 Ganciclovir 52 Phase 2a trial 52 developing ViaCyte SM 52 Viread tenofovir disoproxil fumarate 52 Mepact 52 ancrod 52 Yervoy 52 Kamada AAT 52 transcriptase inhibitors NNRTIs 52 Oxaliplatin 52 cutaneous T 52 Myolimus 52 oral transmucosal 52 oral Janus kinase 52 OncoVex 52 ATL# [002] 52 efficacy 52 refractory chronic myeloid 52 Preclinical studies suggest 52 AA amyloidosis 52 VNP#M 52 Xinlay 52 TAXUS Element Paclitaxel Eluting 52 TÎ ² 4 52 ALGRX 52 Enbrel etanercept 52 IV acetaminophen 52 CCR5 receptor antagonist 52 ADP receptor antagonist 52 Tipranavir 52 Valopicitabine 52 Valtropin 52 budesonide foam 52 Erbitux cetuximab 52 AZILECT ® 52 pregabalin Lyrica 52 Phase 2b clinical trials 52 pegylated interferon alfa 2a 52 teduglutide 52 erlotinib Tarceva 52 HGS# 52 aflibercept VEGF Trap 52 Ceftobiprole 52 Nabi HB 52 Orazol 52 oral immunomodulatory 52 eniluracil 52 prostate cancer HRPC 52 SparVax TM 52 immune modulation 52 Loramyc R 52 Advanced Melanoma 52 fosbretabulin 52 Theratope 52 refractory AML 52 Zalbin 52 Epivir 52 Eluting Coronary Stent System 52 Rebif ® 52 Phase 1b trial 52 Plasmin 52 systemic fungal infections 52 histone deacetylase HDAC inhibitors 52 Linjeta TM 52 Sorafenib Nexavar 52 gastrointestinal stromal tumors GIST 52 chronic HCV infection 52 aripiprazole Abilify 51 mycophenolate mofetil 51 HDAC inhibitor 51 Vivitrex 51 efalizumab 51 investigational oral hepatitis C 51 clinical trials SGN 51 QLT# 51 Rheumatoid Arthritis RA 51 Phase 2a 51 metformin HCl 51 EVIZON TM 51 vaginal candidiasis 51 nucleotide analogue 51 Zenvia Phase III 51 Cerimon 51 Vaccine Candidate 51 Raltegravir 51 hoFH 51 Phase IIIb clinical 51 Vertex hepatitis C 51 Emezine 51 Phase III clinical 51 Tindamax R 51 Arzerra ofatumumab 51 AV HALT 51 NNRTIs 51 PREZISTA r 51 Phase IIb clinical 51 Actemra 51 PEG interferon 51 basiliximab 51 BRAF V# mutation 51 BENLYSTA TM 51 mg kg BID 51 HCV polymerase inhibitor 51 TNF alpha antagonist 51 ruxolitinib 51 Aztreonam 51 DEB# 51 infliximab Remicade 51 treat nicotine addiction 51 oral formulation 51 anti TNF alpha 51 Lysteda 51 Phase IIa trial 51 immunomodulatory 51 Atacicept 51 paliperidone palmitate 51 IND submission 51 Augment Bone Graft 51 VGV 1 51 TAXUS TM 51 topical non steroidal 51 vapreotide acetate 51 Virulizin R 51 diabetic macular edema DME 51 Tekturna HCT 51 urethral bulking agent 51 dacetuzumab 51 Oxiplex 51 Dacogen decitabine 51 Chronic Myeloid Leukemia CML 51 Liprostin 51 FOLFOX chemotherapy 51 RG# [001] 51 tasisulam 51 Loxapine 51 Combidex 51 GV# [001] 51 ZoMaxx 51 intravenous formulation 51 Increlex R 51 HIV integrase inhibitor 51 Octreolin 51 CCR5 inhibitors 51 Teflaro 51 baminercept 51 Hepatitis C Virus HCV 51 Ampligen R 51 Removab 51 Certolizumab pegol 51 levetiracetam Keppra 51 DURIN TM 51 balsalazide tablet 51 CERVARIX R 51 chemotherapy cisplatin 51 casopitant 51 opioid analgesic 51 gastrointestinal stromal tumor GIST 51 zidovudine AZT 51 Orapred ODT 51 PREOS 51 Natalizumab 51 ISENTRESS 51 iniparib 51 subcutaneously administered 51 Neugene 51 preclinical studies 51 DNAwithPap TM Test 51 prokinetic agent 51 LHRH analogues 51 injectable enzyme 51 Known generically 51 Iressa gefitinib 51 AA Amyloidosis 51 Oxytrex 51 Bremelanotide 51 ocrelizumab 51 dexpramipexole 51 STELARA TM 51 hepatitis C viral infection 51 relapsing remitting MS RRMS 51 Peramivir 51 JANUVIA 51 Myelodysplastic Syndrome MDS 51 Phase IIa trials 51 protease inhibitor 51 oral dual endothelin 51 opioid receptor antagonist 51 HepaGam B 51 Drug Eluting Stent System 51 FIRAZYR 51 pegylated interferon alpha 51 USL# 51 RhuDex 51 Ipilimumab 51 intravenously administered 51 RH1 50 virus HCV infection 50 UCB Cimzia 50 TASKi3 50 cabazitaxel 50 Naive Patients 50 chronic hepatitis C. 50 Orphan Drug 50 tasocitinib 50 Chronic Lymphocytic Leukemia 50 SARMs 50 Phase 2b clinical 50 Desmoteplase 50 antifungal agent 50 echinocandin 50 metastatic colorectal cancer 50 MAXY alpha 50 direct renin inhibitor 50 taxane chemotherapy 50 thrombin inhibitor 50 elvitegravir 50 HCV infection 50 topical antifungal 50 prostate cancer CRPC 50 Viprinex 50 acute decompensated heart 50 invasive candidiasis 50 Aptivus 50 pivotal Phase 50 bacillus Calmette Guerin BCG 50 oral antifungal 50 Prochymal 50 leukemia AML 50 Rifaximin 50 TREDAPTIVE 50 metastatic gastric 50 Anti TNF 50 INC# 50 Litx 50 EOquin R 50 APTIVUS R 50 Orphan Drug designations 50 Japanese Encephalitis vaccine